Rallybio to Present at Upcoming Investor Conferences in March

Author's Avatar
Mar 01, 2023

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: